Geoerger, Birgit http://orcid.org/0000-0003-4361-3643
Schiff, Manuel http://orcid.org/0000-0001-8272-232X
Penard-Lacronique, Virginie
Darin, Niklas
Saad, Selim-Maria
Duchon, Clarisse
Lamazière, Antonin
Desmons, Aurore
Pontoizeau, Clément
Berlanga, Pablo
Ducassou, Stéphane
Yen, Katharine
Su, Michael
Schenkein, David
Ottolenghi, Chris
De Botton, Stéphane
Funding for this research was provided by:
Institut National Du Cancer (AcSe program)
Fondation ARC pour la Recherche sur le Cancer
Article History
Received: 7 October 2022
Accepted: 1 May 2023
First Online: 29 May 2023
Competing interests
: D.S. is a current board member at Agios Pharmaceuticals and a current shareholder of Agios Pharmaceuticals. The other authors declare no competing interests.